Powered By MRP Raises Series A Funding from Aries Capital Partners and Swell Collective

Globally recognized aesthetics device company Powered By MRP is pleased to announce a strategic partnership with prominent Utah-based Growth Equity firms, Aries Capital Partners and Swell Collective. The Series A investment marks a pivotal moment in Powered By MRP’s growth trajectory as it brings together unparalleled expertise and resources to accelerate the company’s expansion plans and market presence.

The round was led by Aries Capital Partners and Swell Collective.

Aries Capital Partners brings decades of experience in identifying and nurturing high-growth companies, the firm is led by Rick Durham and Jason Reading. Their commitment to fostering innovation and driving operational excellence aligns seamlessly with Powered By MRP’s mission to revolutionize the aesthetics device industry.

“The aesthetic device market has undergone dramatic transformation in the last five years and will continue to evolve quickly in how these devices are marketed and serviced,” said Jason Reading, Partner at Aries Capital Partners. “To meet this challenge, Scott Carson, Founder and CEO, has assembled a world-class team and a vision on how to better service the needs of both end-users and manufacturers of aesthetic laser devices. He has the clinician and business owner in mind and wants to make the process of buying, selling, and servicing devices transparent to the end-user. We are excited to partner with Scott and his team to make his vision a reality,” said Reading.
Swell Collective is a new growth equity fund led by experienced investors Aaron DeRose and Alex Daines, with Jeremy Andrus (current CEO of Traeger Grills and former CEO of Skullcandy) serving as an advisor and investor. The Swell Collective team has extensive experience investing in high-growth companies and understands deeply the nexus of consumer experience and technology. Their strong track record and operating background makes them an ideal partner for the next stage of growth for Powered By MRP.
“We became interested in MRP when we learned of the strong tailwinds behind the aesthetics market. When we met Scott and the rest of the Powered By MRP team, we quickly realized the amazing potential of the business,” said Alex Daines, Principal at Swell Collective. “With strong foundations already in place, this growth capital will help fuel Powered By MRP to be a dominant player in the aesthetics industry, while continuing to provide best-in-class service to the physicians and clinicians it serves.”
Since its founding in 2015, Powered By MRP has earned global recognition for its technology-driven platform. The company offers a vertically-integrated e-commerce platform that empowers aesthetic providers with consultative customer service and GPO-level pricing. As the largest reseller of new and pre-owned energy-based aesthetic and surgical devices worldwide, Powered By MRP continues to redefine industry standards and elevate customer experiences.

“As a data rich aesthetics device company, this partnership is a testament to our innovation and dedication to excellence,” said Scott Carson, Founder and CEO of Powered By MRP. “Now, being partially owned by two of the most prestigious Growth Equity firms in the country, we’re poised for even greater care to the physicians, clinicians and administrators we serve. I am proud of the entire MRP team that even in this very difficult equity market, MRP raised capital well above the median for a Series A, affirming our position as a leader in the industry and setting a new standard for growth and innovation,” he said.
As part of the transaction, Jason Reading (Aries) and Alex Daines (Swell) will be joining the Powered By MRP Board of Directors. This is alongside founding members Scott and Marilyn Carson as well as Jonathan Nielsen (previously Backcountry.com CEO). As the company enters its next stage of growth, deepening its e-commerce, technology infrastructure, and logistics platforms, both Jonathan Nielsen and Powered By MRP CFO Shaun Groat, will play integral roles in the company’s growth.
In alignment with its expansion strategy, Powered By MRP is actively planning to expand its facilities in key locations, including Salt Lake City and the Mid-Atlantic region. These expansion efforts signify the company’s commitment to meeting the growing demands of its customer base while solidifying its position as a leader in the market. “The capital raised enables us to expand our capabilities to better serve our customers and drive innovation and ultimately the cost of healthcare to all patients,” Carson concluded.

Other co-Investors in the Series A included Broadhaven Capital Partners, Jeff Lee and Chris Koh.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.